AstraZeneca pauses coronavirus vaccine trial, what does this mean for markets?

AstraZeneca COVID-19 vaccine trial paused due to suspected adverse reaction

AstraZeneca COVID-19 vaccine trial paused due to suspected adverse reaction

"As far as Indian trials are concerned, it is continuing and we have faced no issues at all", SII said in a statement.

"We, the undersigned biopharmaceutical companies, want to make clear our on-going commitment to developing and testing potential vaccines for COVID-19 in accordance with high ethical standards and sound scientific principles", a statement read that was signed by the CEOs of AstraZeneca, BioNTech GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi.

The vaccine is being developed by Oxford University and AstraZeneca, and the illness of the volunteer has yet to be disclosed publicly.

The nature of the illness and when it happened were not detailed, although the participant is expected to recover, according to Stat News, which first reported the suspension due to a "suspected serious adverse reaction".

The company is now trying to figure out if the illness is a side-effect of the vaccine, which was in the late stages of trials.

Brazil's health authority said later on Tuesday that AstraZeneca had halted the clinical trial and that it was waiting for more information on why, seemingly corroborating the report in STAT.

Broncos star Von Miller might have sustained serious ankle injury
Denver Broncos star linebacker Von Miller suffered a season-ending ankle injury at the end of the team's practice on Tuesday. ESPN's Adam Schefter reports that one witness described it as a "freak" injury to his ankle suffered late in practice.

"The ethics committees for the Indian sites should be intervening", he told News18.

The third phase of clinical trials of the Sputnik V vaccine will start on 9 September, according to the Russian Health Ministry which has gathered nearly 31,000 volunteers to take part. At least 1,600 candidates aged between 18 to 55, will participate in the trial.

In the United Kingdom, the Lancet published data on trials of AstraZeneca that indicated that the vaccine candidate produced a dual immune response in people aged 18 to 55.

The vaccine being tested was created by teams from both AstraZeneca and the University of Oxford. Science is hard. This is why we have to let the trials play out.

Venezuela's President Nicolas Maduro has proposed giving the first batch of a Russian coronavirus vaccine to candidates in upcoming legislative elections, which are being boycotted by the main opposition parties. "But optimism isn't evidence".

"Manufacturing capacity of Serum Institute is unimaginable - 75 to 100 million doses per month", Dr VK Paul, head of India's National Task Force on Covid-19 said.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.